A5059143060- Obstructive Sleep Apnea Research
- Sleep and related disorders
- Diet and metabolism studies
- Neuroscience of respiration and sleep
- Child Nutrition and Feeding Issues
- Healthcare Policy and Management
- Asthma and respiratory diseases
- Healthcare cost, quality, practices
- Tracheal and airway disorders
- Pharmaceutical studies and practices
- Medication Adherence and Compliance
- Respiratory Support and Mechanisms
- Health, Education, and Physical Culture
- Global Health Care Issues
ResMed (Netherlands)
2022-2024
ScienceMedia (United States)
2022
ResMed (United States)
2022
Rationale: The co-occurrence of obstructive sleep apnea and chronic pulmonary disease, termed overlap syndrome, has a poor prognosis. However, data on positive airway pressure (PAP) treatments their impact outcomes costs are lacking. Objectives: This retrospective observational study investigated the effects PAP health outcomes, resource usage, in patients with syndrome. Methods: Deidentified adjudicated claims for syndrome United States were linked to objectively measured user data....
Rationale: Clear definition of optimal positive airway pressure therapy usage in patients with obstructive sleep apnea is not possible because scarce data on the relationship between hours and major clinical outcomes. Objective: To investigate dose–response healthcare resource utilization determine minimum device required for benefit. Methods: A linked set combined deidentified payer-sourced administrative medical/pharmacy claims from more than 100 U.S. health plans individual patient data....
Study Objectives: There is a complex interplay between obstructive sleep apnea (OSA) and type 2 diabetes.There are minimal data regarding the effects of treating OSA with positive airway pressure (PAP) therapy on outcomes health care resource utilization (HCRU) in patients diabetes.We investigated impact PAP adherence HCRU costs this population.Methods: A retrospective analysis was conducted cohort patient from US administrative claims dataset linked to objective device (AirView, ResMed...
Abstract Introduction Insomnia and obstructive sleep apnea (OSA), comorbidly known as COMISA, are the two most common disorders, with each impairing treatment efficacy for other. Real-world studies on of patients COMISA lacking, thus this study aimed to examine clinical economic impact treating OSA positive airway pressure (PAP) therapy in population. Methods This retrospective linked administrative claims data PAP device usage newly diagnosed initiating (index date) between January 2015...
Abstract Introduction Depression and obesity are both prevalent among patients with obstructive sleep apnea (OSA). Treating OSA has been shown to improve depressive symptoms. Routine treatment for often includes positive airway pressure (PAP) therapy combined weight management strategies, including glucagon-like peptide 1 receptor agonists (GLP-1s), which have approved treat type 2 diabetes (T2D) obesity. Little is known about the relationship between GLP-1 use depression patterns, or how...
Abstract Introduction Obstructive sleep apnea (OSA) and obesity are strongly associated highly prevalent in the United States (US). Routine treatment for OSA often includes positive airway pressure (PAP) therapy combined with weight management strategies, more recently including use of glucagon-like peptide 1 (GLP-1) receptor agonists. This real-world analysis assessed impact recent GLP-1 on PAP over year non-diabetic patients PAP-treated obesity. Methods Administrative claims data from...
Abstract Introduction Obesity is a modifiable risk factor for obstructive sleep apnea (OSA). Weight management interventions have been shown to reduce OSA symptoms and severity some patients. This retrospective analysis aimed evaluate the impact of weight reduction surgery or procedure (WRS/P) on pressure changes in positive airway (PAP) treated patients as proxy following surgery. Methods We analyzed administrative claims data from 2015 2021 adult (≥18 years) linked PAP device data. The...
Abstract Introduction Obstructive sleep apnea (OSA) and depression commonly co-exist have complex relationships. Depressive symptoms may be a particularly common manifestation of OSA among women, with women going undiagnosed for many years. Conversely, effective treatment improve control. We sought to evaluate the relationship between including impact treatment, how this varies by gender. Methods linked administrative claims data objective positive airway pressure (PAP) therapy device usage...
Abstract Introduction Patients diagnosed with obstructive sleep apnea (OSA) and prescribed positive airway pressure (PAP) therapy for treatment may have differences in experience based on insurance provider, sex, age, or comorbidity status. This retrospective, real-world analysis investigated the factors that impact patient’s OSA journey from initial test to starting PAP therapy. Methods De-identified US administrative claims data patients who had a claim were used this analysis. Age,...
Abstract Introduction Real-world evidence focused on women with obstructive sleep apnea (OSA) is lacking. This retrospective study aimed to characterize and evaluate the impact of age female patients OSA their journey through diagnosis treatment. Methods De-identified US administrative claims data for who had a claim test were used this analysis. Age insurance coverage characterized at time first test. Comorbidity status was evaluated in year prior by assessing ICD-9/10 codes associated...